We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 1,642 results
  1. Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas

    Background

    The incidence of multicentric oral cancer is increasing. However, treatment encounters difficulty if each tumor needs to be treated...

    Xuefei Chen, Mitomu Kioi, ... Kenji Mitsudo in Radiation Oncology
    Article Open access 26 May 2023
  2. Quantitative phosphoproteomics to unravel the cellular response to chemical stressors with different modes of action

    Damage to cellular macromolecules and organelles by chemical exposure evokes activation of various stress response pathways. To what extent different...

    Bharath Sampadi, Alex Pines, ... Harry Vrieling in Archives of Toxicology
    Article Open access 18 March 2020
  3. Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review

    For peritoneal metastases (PM), there are few curative treatment options, and they are only available for a select patient group. Recently, new...

    Anne G. W. E. Wintjens, Geert A. Simkens, ... Andrea Peeters in Clinical & Experimental Metastasis
    Article Open access 23 June 2022
  4. Chemoresistance in Colorectal Malignancies: Molecular Mechanisms and Strategies to Overcome.

    Colorectal cancer (CRC) remains the third most common cause of cancer-related deaths in both men and women worldwide. Despite recent advances in...
    Henu Kumar Verma, Yashwant Kumar Ratre, Pellegrino Mazzone in Colon Cancer Diagnosis and Therapy Vol. 3
    Chapter 2022
  5. Antibody-Functionalized Nanoparticles for Targeted Drug Delivery in Cancer Therapy

    Targeted therapies using nanoparticles have been proposed to address some drawbacks of conventional chemotherapy. In the last two decades, surface...
    Ana Camila Marques, Paulo Cardoso da Costa, ... Maria Helena Amaral in Handbook of Cancer and Immunology
    Living reference work entry 2023
  6. Role of Copolymers in Lung Cancer

    Hydrogels, micelles, dendrimers, simple and functionalized nanoparticles, mesoporous particles, and liposomes have all been used effectively to...
    Chapter 2023
  7. Integrative approach using network pharmacology, bioinformatics, and experimental methods to explore the mechanism of cantharidin in treating colorectal cancer

    Cantharidin, a terpenoid produced by blister beetles, has been used in traditional Chinese medicine to treat various ailments and cancers. However,...

    Benchao Hou, **aomin Wang, ... Haiyun Liu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 20 March 2024
  8. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells

    Background

    Drug resistance is a major obstacle to treating cancers because it desensitizes cancer cells to chemotherapy. Recently, attention has been...

    Haifang Wang, Chen Fu, ... Yurong Qiu in Journal of Experimental & Clinical Cancer Research
    Article Open access 05 February 2020
  9. Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer

    The impressive successes of immune checkpoint blockade antibodies to treat various types of cancer are limited to minor subsets of patients....

    Kabir A. Khan, José L. Ponce de Léon, ... Robert S. Kerbel in npj Breast Cancer
    Article Open access 20 July 2020
  10. Immune Response to SARS-CoV-2 Infections in Children with Secondary Immunodeficiencies

    Background and Purpose

    It is a matter of research, whether children with immunodeficiencies are able to generate an effective immune response to...

    Karolina Kuczborska, Ewelina Krzemińska, ... Janusz Książyk in Journal of Clinical Immunology
    Article Open access 23 September 2022
  11. Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant

    Purpose

    Aprepitant is used with dexamethasone and 5-HT 3 receptor antagonists as an antiemetic treatment for chemotherapy, including cisplatin....

    Hideyuki Hibino, Naomi Sakiyama, ... Hisakazu Ohtani in European Journal of Clinical Pharmacology
    Article 17 January 2022
  12. The FOXO family of transcription factors: key molecular players in gastric cancer

    Gastric cancer (GC) is the fifth most frequently diagnosed cancer worldwide and the third leading cause of cancer-related death with an oncological...

    Ying Liu, **ang Ao, ... Jianxun Wang in Journal of Molecular Medicine
    Article 10 June 2022
  13. Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review

    The main treatment of MM metastases are systemic therapies, surgery, limb perfusion, and intralesional talimogene laherparepvec. Electrochemotherapy...

    Martina Ferioli, Valentina Lancellotta, ... Alessio G. Morganti in Clinical & Experimental Metastasis
    Article Open access 22 July 2022
  14. An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection

    Cisplatin (CDDP) is one of the most important chemotherapeutic drugs in modern oncology. However, its use is limited by severe toxicities, which...

    Anna Hucke, Markus M. Rinschen, ... Giuliano Ciarimboli in Archives of Toxicology
    Article 06 September 2019
  15. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes

    Background

    Esophagectomy is the standard adjuvant treatment for superficial esophageal squamous cell carcinoma (SESCC) following noncurative...

    Gen Suzuki, Hideya Yamazaki, ... Kei Yamada in Radiation Oncology
    Article Open access 19 November 2022
  16. Comprehensive screening for drugs that modify radiation-induced immune responses

    Background

    Combination therapy based on radiotherapy and immune checkpoint inhibitors (ICIs) was recently reported as effective for various cancers....

    Masayuki Okumura, Junyan Du, ... Tetsuo Akimoto in British Journal of Cancer
    Article Open access 19 February 2022
  17. E-Jet 3D-Printed Scaffolds as Sustained Multi-Drug Delivery Vehicles in Breast Cancer Therapy

    Purpose

    Combination chemotherapy is gradually receiving more attention because of its potential synergistic effect and reduced drug doses in clinical...

    **aoyin Qiao, Yikun Yang, ... Zhikai Tan in Pharmaceutical Research
    Article 18 November 2019
  18. Survival outcomes of esophageal cancer patients with recurrence after curative treatments

    Background

    Little is known about predictive factors for survival outcomes of esophageal carcinoma (EC) patients who developed recurrence after...

    Kotaro Sugawara, Daiji Oka, ... Takashi Fukuda in BMC Cancer
    Article Open access 01 November 2023
  19. Tumor Microenvironment and Tumor-Targeted Therapy

    Cancer tissue or cancer cells do not exist in isolation, but start life within the microenvironment called tumor microenvironment (TME). The...
    Hongxia Duan, Wei Huang in Handbook of Cancer and Immunology
    Living reference work entry 2023
  20. Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE

    Background

    Standard care for non-metastatic squamous cell carcinoma of the anus (SCCA) is chemoradiotherapy, data about elderly patients are scarce.

    ...
    Claire Gouriou, Claire Lemanski, ... Astrid Lièvre in British Journal of Cancer
    Article 06 January 2024
Did you find what you were looking for? Share feedback.